Access the full text.
Sign up today, get DeepDyve free for 14 days.
E. Abraham, A. Anzueto, G. Gutierrez, S. Tessler, G. Pedro, R. Wunderink, A. Nogare, S. Nasraway, S. Berman, R. Cooney, H. Levy, R. Baughman, M. Rumbak, R. Light, L. Poole, R. Allred, J. Constant, J. Pennington, S. Porter (1998)
Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group.Lancet, 351 9107
Y. Moriwaki, Tetsuya Yamamoto, Y. Shibutani, Eiji Aoki, Z. Tsutsumi, Sumio Takahashi, H. Okamura, M. Koga, M. Fukuchi, T. Hada (2003)
Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy.Metabolism: clinical and experimental, 52 5
S. Rauchschwalbe, T. Maseizik, U. Mittelkötter, B. Schlüter, C. Patzig, A. Thiede, H. Reith (2004)
Effect of the LT-α (+250 G/A) Polymorphism on Markers of Inflammation and Clinical Outcome in Critically Ill PatientsJournal of Trauma-injury Infection and Critical Care, 56
S. Schroeder, M. Reck, A. Hoeft, F. Stüber (1999)
Analysis of two human leukocyte antigen-linked polymorphic heat shock protein 70 genes in patients with severe sepsis.Critical care medicine, 27 7
O. Schröder, K. Schulte, P. Ostermann, H. Röher, A. Ekkernkamp, R. Laun (2003)
Heat shock protein 70 genotypes HSPA1B and HSPA1L influence cytokine concentrations and interfere with outcome after major injury*Critical Care Medicine, 31
A. Treszl, I. Kocsis, M. Szathmári, Á. Schuler, E. Heninger, T. Tulassay, B. Vásárhelyi (2003)
Genetic variants of TNF-[FC12]a, IL-1beta, IL-4 receptor [FC12]a-chain, IL-6 and IL-10 genes are not risk factors for sepsis in low-birth-weight infants.Biology of the neonate, 83 4
(2004)
IL-10 haplotypes are not associated with survival and organ dysfunction in critically ill patients with the systemic inflammatory response syndrome
E. Lorenz, J. Mira, Kristyn Cornish, N. Arbour, D. Schwartz (2000)
A Novel Polymorphism in the Toll-Like Receptor 2 Gene and Its Potential Association with Staphylococcal InfectionInfection and Immunity, 68
M. Alessi, D. Bastelica, P. Morange, B. Berthet, I. Leduc, M. Verdier, O. Geel, I. Juhan-Vague (2000)
Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity.Diabetes, 49 8
A. Cariou, J. Chiche, J. Charpentier, J. Dhainaut, J. Mira (2002)
The era of genomics: Impact on sepsis clinical trial designCritical Care Medicine, 30
J. Pritchard, P. Donnelly (2001)
Case-control studies of association in structured or admixed populations.Theoretical population biology, 60 3
B. Hou, M. Eren, C. Painter, Joseph Covington, J. Dixon, J. Schoenhard, D. Vaughan (2004)
Tumor Necrosis Factor α Activates the Human Plasminogen Activator Inhibitor-1 Gene through a Distal Nuclear Factor κB Site*Journal of Biological Chemistry, 279
J. Helge, B. Stallknecht, B. Pedersen, H. Galbo, B. Kiens, E. Richter (2003)
The effect of graded exercise on IL‐6 release and glucose uptake in human skeletal muscleThe Journal of Physiology, 546
S. Rauchschwalbe, T. Maseizik, U. Mittelkötter, B. Schlüter, C. Patzig, A. Thiede, H. Reith (2004)
Effect of the LT-alpha (+250 G/A) polymorphism on markers of inflammation and clinical outcome in critically ill patients.The Journal of trauma, 56 4
S. Blankenberg, G. Luc, P. Ducimetiere, D. Arveiler, J. Ferrières, P. Amouyel, A. Evans, F. Cambien, L. Tiret (2003)
Interleukin-18 and the Risk of Coronary Heart Disease in European Men: The Prospective Epidemiological Study of Myocardial Infarction (PRIME)Circulation: Journal of the American Heart Association, 108
B. Schlüter, C. Raufhake, M. Erren, H. Schotte, F. Kipp, S. Rust, H. Aken, G. Assmann, E. Berendes (2002)
Effect of the interleukin-6 promoter polymorphism (−174 G/C) on the incidence and outcome of sepsisCritical Care Medicine, 30
M. Ingelman-Sundberg (2004)
Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future.Trends in pharmacological sciences, 25 4
D. Eisen, R. Minchinton (2003)
Impact of mannose-binding lectin on susceptibility to infectious diseases.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 37 11
R. Barber, G. O’Keefe (2003)
Characterization of a single nucleotide polymorphism in the lipopolysaccharide binding protein and its association with sepsis.American journal of respiratory and critical care medicine, 167 10
L. Kruglyak, D. Nickerson (2001)
Variation is the spice of lifeNature Genetics, 27
E. Carswell, L. Old, R. Kassel, S. Green, N. Fiore, B. Williamson (1975)
An endotoxin-induced serum factor that causes necrosis of tumors.Proceedings of the National Academy of Sciences of the United States of America, 72 9
R. Mesters, N. Flörke, H. Ostermann, J. Kienast (1996)
Increase of Plasminogen Activator Inhibitor Levels Predicts Outcome of Leukocytopenic Patients with SepsisThrombosis and Haemostasis, 75
G. Waterer, M. Quasney, R. Cantor, R. Wunderink (2001)
Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations.American journal of respiratory and critical care medicine, 163 7
M. Saleh, J. Vaillancourt, R. Graham, M. Huyck, S. Srinivasula, E. Alnemri, M. Steinberg, V. Nolan, C. Baldwin, R. Hotchkiss, T. Buchman, B. Zehnbauer, M. Hayden, L. Farrer, Sophie Roy, D. Nicholson (2004)
Differential modulation of endotoxin responsiveness by human caspase-12 polymorphismsNature, 429
D. Mcglasson (2004)
Oral AnticoagulantsAmerican Society for Clinical Laboratory Science, 17
F. Stuber, Marc Petersen, F. Bokelmann, U. Schade (1996)
A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis.Critical care medicine, 24 3
TNF-b +252A allele associated with increased peak TNF-a serum levels and increased mortality from severe sepsis
Jacqueline Calvano, J. Um, D. Agnese, Sae Hahm, Ashish Kumar, S. Coyle, S. Calvano, S. Lowry (2003)
Influence of the TNF-α and TNF-β polymorphisms upon infectious risk and outcome in surgical intensive care patientsSurgical Infections, 4
(cid:2) 308A allele associated with increased mortality and higher peak TNF-a levels in patients with septic shock
Penglin Ma, Dechang Chen, Jiaqi Pan, B. Du (2002)
Genomic polymorphism within interleukin-1 family cytokines influences the outcome of septic patients*Critical Care Medicine, 30
A. Koch, M. Melbye, P. Sørensen, P. Homøe, H. Madsen, K. Mølbak, C. Hansen, L. Andersen, G. Hahn, P. Garred (2001)
Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood.JAMA, 285 10
G. Tang, Song-Lih Huang, H. Yien, Wei-Shone Chen, C. Chi, Chew‐Wun Wu, W. Lui, J. Chiu, Tak-Yu Lee (2000)
Tumor necrosis factor gene polymorphism and septic shock in surgical infectionCritical Care Medicine, 28
Eva Lorenz, Jean Mira, Kathy Frees, David Schwartz (2002)
Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock.Archives of internal medicine, 162 9
M. Shaw, J. Schoones (2004)
Laennec, tréma, and tuberculosis.American journal of respiratory and critical care medicine, 169 10
B. Devlin, K. Roeder (1999)
Genomic Control for Association StudiesBiometrics, 55
H. Tómasdóttir, H. Hjartarson, A. Ricksten, C. Wasslavik, A. Bengtsson, S. Ricksten (2003)
Tumor Necrosis Factor Gene Polymorphism Is Associated with Enhanced Systemic Inflammatory Response and Increased Cardiopulmonary Morbidity After Cardiac SurgeryAnesthesia & Analgesia, 97
Jaroslav Hubacek, Frank Stüber, D. Fröhlich, M. Book, S. Wetegrove, G. Rothe, Gerd Schmitz (2000)
The common functional C(−159)T polymorphism within the promoter region of the lipopolysaccharide receptor CD14 is not associated with sepsis development or mortalityGenes and Immunity, 1
Y. Nagai, S. Akashi, M. Nagafuku, M. Ogata, Y. Iwakura, S. Akira, T. Kitamura, A. Kosugi, M. Kimoto, K. Miyake (2002)
Essential role of MD-2 in LPS responsiveness and TLR4 distributionNature Immunology, 3
M. Baldini, I. Lohman, M. Halonen, R. Erickson, P. Holt, F. Martinez (1999)
A Polymorphism* in the 5' flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E.American journal of respiratory cell and molecular biology, 20 5
Wei Wang, M. Boffa, L. Bajzar, J. Walker, M. Nesheim (1998)
A Study of the Mechanism of Inhibition of Fibrinolysis by Activated Thrombin-activable Fibrinolysis Inhibitor*The Journal of Biological Chemistry, 273
R. Cann (1995)
The history and geography of human genesThe Journal of Asian Studies, 54
V. Irikura, M. Lagraoui, D. Hirsh (2002)
The Epistatic Interrelationships of IL-1, IL-1 Receptor Antagonist, and the Type I IL-1 Receptor1The Journal of Immunology, 169
M. Majetschak, U. Obertacke, F. Schade, M. Bardenheuer, G. Voggenreiter, B. Bloemeke, M. Heesen (2002)
Tumor Necrosis Factor Gene Polymorphisms, Leukocyte Function, and Sepsis Susceptibility in Blunt Trauma PatientsClinical and Vaccine Immunology, 9
Y. Ando, D. Price, W. Dahut, M. Cox, E. Reed, William II (2002)
Pharmacogenetic Associations of CYP2C19 Genotype with In Vivo Metabolisms and Pharmacological Effects of ThalidomideCancer Biology & Therapy, 1
David Wang, J. Fan, C. Siao, A. Berno, Peter Young, R. Sapolsky, G. Ghandour, Nancy Perkins, E. Winchester, Jessica Spencer, L. Kruglyak, Lincoln Stein, L. Hsie, T. Topaloglou, E. Hubbell, Elizabeth Robinson, Mike Mittmann, M. Morris, Naiping Shen, D. Kilburn, J. Rioux, C. Nusbaum, S. Rozen, T. Hudson, R. Lipshutz, M. Chee, E. Lander (1998)
Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome.Science, 280 5366
D. Tamandl, Minu Bahrami, B. Wessner, G. Weigel, M. Ploder, W. Fürst, E. Roth, G. Boltz‐Nitulescu, A. Spittler (2003)
Modulation of Toll-Like Receptor 4 Expression on Human Monocytes by Tumor Necrosis Factor and Interleukin-6: Tumor Necrosis Factor Evokes Lipopolysaccharide Hyporesponsiveness, Whereas Interleukin-6 Enhances Lipopolysaccharide ActivityShock, 20
P. Hermans, M. Hibberd, R. Booy, O. Daramola, J. Hazelzet, R. Groot, M. Levin (1999)
4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal diseaseThe Lancet, 354
J. Hovinga, R. Franco, M. Zago, H. Cate, R. Westendorp, P. Reitsma (2004)
A functional single nucleotide polymorphism in the thrombin‐activatable fibrinolysis inhibitor (TAFI) gene associates with outcome of meningococcal diseaseJournal of Thrombosis and Haemostasis, 2
Dr Robinson (2001)
Paediatric origins of adult lung disease bullet 7: Cystic fibrosisThorax, 56
C. Hedberg, K. Adcock, Jeremy Martin, J. Loggins, Thomas Kruger, R. Baier (2004)
Tumor Necrosis Factor &agr; −308 Polymorphism Associated With Increased Sepsis Mortality in Ventilated Very Low Birth Weight InfantsThe Pediatric Infectious Disease Journal, 23
C. Reid, C. Perrey, V. Pravica, I. Hutchinson, I. Campbell (2002)
Genetic variation in proinflammatory and anti-inflammatory cytokine production in multiple organ dysfunction syndrome*Critical Care Medicine, 30
A. Rosenblatt, R. Brinkman, K. Liang, E. Almqvist, R. Margolis, C. Huang, M. Sherr, M. Franz, M. Abbott, M. Hayden, C. Ross (2001)
Familial influence on age of onset among siblings with Huntington disease.American journal of medical genetics, 105 5
M. Nesheim, J. Taswell, K. Mann (1979)
The contribution of bovine Factor V and Factor Va to the activity of prothrombinase.The Journal of biological chemistry, 254 21
H. Madsen, P. Garred, S. Thiel, J. Kurtzhals, L. Lamm, L. Ryder, A. Svejgaard (1995)
Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein.Journal of immunology, 155 6
J. Hubacek, F. Stüber, D. Fröhlich, M. Book, S. Wetegrove, M. Ritter, G. Rothe, G. Schmitz (2001)
Gene variants of the bactericidal/permeability increasing protein and lipopolysaccharide binding protein in sepsis patients: Gender-specific genetic predisposition to sepsisCritical Care Medicine, 29
H. Okamura, H. Tsutsi, T. Komatsu, M. Yutsudo, A. Hakura, T. Tanimoto, K. Torigoe, T. Okura, Y. Nukada, K. Hattori (1995)
Cloning of a new cytokine that induces IFN-gamma production by T cells.Nature, 378 6552
Increased mortality rate for male TNF-b +252AA homozygotes (no difference for females)
Jacqueline Calvano, J. Um, D. Agnese, Sae Hahm, A. Kumar, S. Coyle, S. Calvano, S. Lowry (2003)
Influence of the TNF-alpha and TNF-beta polymorphisms upon infectious risk and outcome in surgical intensive care patients.Surgical infections, 4 2
association between TNF-a (cid:2) 308 genotype and serum levels of TNF-a or outcome from severe sepsis
T. Menges, P. Hermans, S. Little, T. Langefeld, O. Böning, J. Engel, M. Sluijter, R. Groot, G. Hempelmann (2001)
Plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism and prognosis of severely injured patientsThe Lancet, 357
D. Lammas, J. Casanova, D. Kumararatne (2000)
Clinical consequences of defects in the IL‐12‐dependent interferon‐gamma (IFN‐γ) pathwayClinical & Experimental Immunology, 121
T. Glück, J. Silver, M. Epstein, P. Cao, B. Farber, Goyert Sm (2001)
Parameters influencing membrane CD14 expression and soluble CD14 levels in sepsis.European journal of medical research, 6 8
E. Presterl, T. Staudinger, M. Pettermann, A. Lassnigg, H. Burgmann, S. Winkler, M. Frass, W. Graninger (1997)
Cytokine profile and correlation to the APACHE III and MPM II scores in patients with sepsis.American journal of respiratory and critical care medicine, 156 3 Pt 1
J. Mourik, D. Lawrence, D. Loskutoff (1984)
Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells.The Journal of biological chemistry, 259 23
B. Kerlin, S. Yan, Berend Isermann, John Brandt, R. Sood, Bruce Basson, David Joyce, H. Weiler, J. Dhainaut (2003)
Survival advantage associated with heterozygous factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemia.Blood, 102 9
J. Pritchard, M. Stephens, N. Rosenberg, P. Donnelly (2000)
Association mapping in structured populations.American journal of human genetics, 67 1
C. Dinarello (1997)
Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock.Chest, 112 6 Suppl
R. Malefyt, J. Abrams, B. Bennett, C. Figdor, J. Vries (1991)
Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytesThe Journal of Experimental Medicine, 174
Greater occurrence of complications, greater severity of complications, and greater mortality from complications with A allele
R. Watanabe, H. Wada, Yasuyuki Watanabe, M. Sakakura, T. Nakasaki, Y. Mori, M. Nishikawa, E. Gabazza, T. Nobori, H. Shiku (2001)
Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulation.Thrombosis research, 104 1
B. Hou, M. Eren, C. Painter, Joseph Covington, J. Dixon, J. Schoenhard, D. Vaughan (2004)
Tumor necrosis factor alpha activates the human plasminogen activator inhibitor-1 gene through a distal nuclear factor kappaB site.The Journal of biological chemistry, 279 18
(1999)
Complete sequence and gene map of a human major histocompatibility complex. The MHC sequencing consortium.Nature, 401 6756
T. Hoekstra, J. Geleijnse, E. Schouten, C. Kluft (2004)
Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular riskThrombosis and Haemostasis, 91
L. O’Neill, Catherine Greene (1998)
Signal transduction pathways activated by the IL‐1 receptor family: ancient signaling machinery in mammals, insects, and plantsJournal of Leukocyte Biology, 63
S. Akashi, R. Shimazu, H. Ogata, Y. Nagai, K. Takeda, M. Kimoto, K. Miyake (2000)
Cutting Edge: Cell Surface Expression and Lipopolysaccharide Signaling Via the Toll-Like Receptor 4-MD-2 Complex on Mouse Peritoneal Macrophages1The Journal of Immunology, 164
No difference in mortality in sample population
M. Heesen, B. Bloemeke, U. Schade, U. Obertacke, M. Majetschak (2002)
The –260 C→T promoter polymorphism of the lipopolysaccharide receptor CD14 and severe sepsis in trauma patientsIntensive Care Medicine, 28
A. Daly, B. King (2003)
Pharmacogenetics of oral anticoagulants.Pharmacogenetics, 13 5
E. Abraham, A. Anzueto, G. Gutierrez, S. Tessler, Gerry Pedro, R. Wunderink, A. Nogare, S. Nasraway, S. Berman, R. Cooney, H. Levy, R. Baughman, M. Rumbak, R. Light, L. Poole, R. Allred, J. Constant, J. Pennington, S. Porter (1998)
Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shockThe Lancet, 351
N. Stassen, Lisa Leslie-Norfleet, A. Robertson, M. Eichenberger, H. Polk (2002)
Interferon-γ gene polymorphisms and the development of sepsis in patients with trauma *Surgery, 132
D. Moatti, Bassam Haidar, F. Fumeron, Laurent Gauci, O. Boudvillain, P. Seknadji, V. Ollivier, M. Aumont, D. Prost (2000)
A New T-287C Polymorphism in the 5’ Regulatory Region of the Tissue Factor Pathway Inhibitor GeneThrombosis and Haemostasis, 84
(2003)
Association of Mannose-Binding Lectin Polymorphisms with Sepsis and Fatal Outcome, in Patients with Systemic Inflammatory Response Syndrome
S. Yan, D. Nelson (2004)
Effect of factor V Leiden polymorphism in severe sepsis and on treatment with recombinant human activated protein CCritical Care Medicine, 32
Jörg Schröder, Volker Kahlke, M. Book, Frank Stüber (2000)
Gender differences in sepsis: genetically determined?Shock, 14 3
X. Fang, S. Schröder, A. Hoeft, F. Stüber (1999)
Comparison of two polymorphisms of the interleukin-1 gene family: interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis.Critical care medicine, 27 7
R. Wunderink, G. Waterer, R. Cantor, M. Quasney (2002)
Tumor necrosis factor gene polymorphisms and the variable presentation and outcome of community-acquired pneumonia.Chest, 121 3 Suppl
N. Stassen, Lisa Leslie-Norfleet, A. Robertson, M. Eichenberger, H. Polk (2002)
Interferon-gamma gene polymorphisms and the development of sepsis in patients with trauma.Surgery, 132 2
S. Beck, D. Geraghty, H. Inoko, L. Rowen, B. Aguado, S. Bahram, R. Campbell, S. Forbes, T. Guillaudeux, L. Hood, R. Horton, M. Janer, C. Jasoni, A. Madan, S. Milne, M. Neville, A. Oka, S. Qin, G. Ribas-Despuig, J. Rogers, T. Shiina, T. Spies, G. Tamiya, H. Tashiro, J. Trowsdale, Q. Vu, L. Williams, M. Yamazaki (1999)
Complete sequence and gene map of a human major histocompatibility complexNature, 401
A. Wilson, J. Symons, T. McDowell, H. Mcdevitt, G. Duff (1997)
Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.Proceedings of the National Academy of Sciences of the United States of America, 94 7
Carolin Feterowski, K. Emmanuilidis, T. Miethke, K. Gerauer, M. Rump, K. Ulm, B. Holzmann, H. Weighardt (2003)
Effects of functional Toll‐like receptor‐4 mutations on the immune response to human and experimental sepsisImmunology, 109
S. Pääbo (2003)
The mosaic that is our genomeNature, 421
S. Gibot, A. Cariou, L. Drouet, M. Rossignol, L. Ripoll (2002)
Association between a genomic polymorphism within the CD14 locus and septic shock susceptibility and mortality rate*Critical Care Medicine, 30
N. Stassen, C. Breit, L. Norfleet, H. Polk (2003)
IL-18 promoter polymorphisms correlate with the development of post-injury sepsis.Surgery, 134 2
K. Emmanuilidis, H. Weighardt, E. Matevossian, C. Heidecke, K. Ulm, H. Bartels, J. Siewert, B. Holzmann (2002)
DIFFERENTIAL REGULATION OF SYSTEMIC IL-18 AND IL-12 RELEASE DURING POSTOPERATIVE SEPSIS: HIGH SERUM IL-18 AS AN EARLY PREDICTIVE INDICATOR OF LETHAL OUTCOMEShock, 18
G. Waterer, Lama Elbahlawan, M. Quasney, Qing Zhang, L. Kessler, R. Wunderink (2003)
Heat shock protein 70-2+1267 AA homozygotes have an increased risk of septic shock in adults with community-acquired pneumoniaCritical Care Medicine, 31
F. Stüber, I. Udalova, M. Book, Ludmila Drutskaya, D. Kuprash, R. Turetskaya, F. Schade, S. Nedospasov (1995)
-308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter.Journal of inflammation, 46 1
G. Block, M. Aulisio (2000)
Will genetics revolutionize medicine?The New England journal of medicine, 343 20
J. Mira, A. Cariou, F. Grall, C. Delclaux, M. Losser, Fahrad Heshmati, C. Cheval, M. Monchi, J. Teboul, F. Riché, G. Leleu, L. Arbibe, Alexandre Mignon, M. Delpech, J. Dhainaut (1999)
Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study.JAMA, 282 6
(2004)
Interleukin-10 clade 4 (À627C, 734T and 3368A) haplotypes are associated with fewer ICU admissions and a less intense inflammatory response following cardiopulmonary bypass surgery
D. Hinds, R. Stokowski, N. Patil, K. Konvička, D. Kershenobich, D. Cox, D. Ballinger (2004)
Matching strategies for genetic association studies in structured populations.American journal of human genetics, 74 2
D. Agnese, Jacqueline Calvano, Sae Hahm, S. Coyle, S. Corbett, S. Calvano, S. Lowry (2002)
Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections.The Journal of infectious diseases, 186 10
M. Heesen, U. Obertacke, F. Schade, B. Bloemeke, M. Majetschak (2002)
The interleukin-6 G(-174)C polymorphism and the ex vivo interleukin-6 response to endotoxin in severely injured blunt trauma patients.European cytokine network, 13 1
F.-C. Chen, E. Vallender, H. Wang, C. Tzeng, Wen-Hsiung Li (2001)
Genomic divergence between human and chimpanzee estimated from large-scale alignments of genomic sequences.The Journal of heredity, 92 6
John McArdle1, Laurie Whittaker2 (2009)
Cystic FibrosisSemin Respir Crit Care Med, 30
Henry Harpending, A. Rogers (2000)
Genetic perspectives on human origins and differentiation.Annual review of genomics and human genetics, 1
V. Kahlke, C. Schafmayer, B. Schniewind, D. Seegert, S. Schreiber, J. Schröder (2004)
Are postoperative complications genetically determined by TNF-beta NcoI gene polymorphism?Surgery, 135 4
Toshihiro Tanaka (2003)
The International HapMap ProjectNature, 426
S. Knapp, C. Wieland, C. Veer, O. Takeuchi, S. Akira, S. Florquin, T. Poll (2004)
Toll-Like Receptor 2 Plays a Role in the Early Inflammatory Response to Murine Pneumococcal Pneumonia but Does Not Contribute to Antibacterial Defense1The Journal of Immunology, 172
S. Temple, Esther Lim, K. Cheong, C. Almeida, P. Price, K. Ardlie, G. Waterer (2003)
Alleles carried at positions −819 and −592 of the IL10 promoter affect transcription following stimulation of peripheral blood cells with Streptococcus pneumoniaeImmunogenetics, 55
Sally DawsonS, Bjorn Wimans, A. Hamsten, F. Green, S. Humphries, A. Henney (1993)
The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells.The Journal of biological chemistry, 268 15
inflammatory response following cardiopulmonary bypass surgery
Q. Shu, X. Fang, Qixing Chen, F. Stuber (2003)
IL-10 polymorphism is associated with increased incidence of severe sepsis.Chinese medical journal, 116 11
M. Majetschak, S. Flohe, U. Obertacke, J. Schröder, K. Staubach, D. Nast‐Kolb, F. Schade, F. Stüber (1999)
Relation of a TNF gene polymorphism to severe sepsis in trauma patients.Annals of surgery, 230 2
K. Tracey, B. Beutler, S. Lowry, J. Merryweather, S. Wolpe, I. Milsark, R. Hariri, T. Fahey, A. Zentella, J. Albert, G. Shires, A. Cerami (1986)
Shock and tissue injury induced by recombinant human cachectin.Science, 234 4775
A. Treszl, I. Kocsis, M. Szathmári, Á. Schuler, E. Heninger, T. Tulassay, B. Vásárhelyi (2003)
Genetic Variants of TNF-α, IL-1β, IL-4 Receptor α-Chain, IL-6 and IL-10 Genes Are Not Risk Factors for Sepsis in Low-Birth-Weight InfantsNeonatology, 83
J. Weitkamp, F. Stüber, P. Bartmann (2000)
Pilot Study Assessing TNF Gene Polymorphism as a Prognostic Marker for Disease Progression in Neonates with SepsisInfection, 28
G. Nicolaes, B. Dahlbäck (2002)
Factor V and Thrombotic Disease: Description of a Janus-Faced ProteinArteriosclerosis, Thrombosis, and Vascular Biology: Journal of the American Heart Association, 22
The promise of pharmacogenomics lies in the ability to tailor patient therapies based on a genetic risk profile. This risk profile may be based on known literature single nucleotide polymorphisms or it may be encompassed by genome‐wide scans for risk alleles. In either case, it is the polymorphisms of a patient that will be the focus in the search for better individualized therapies. The risk profile for sepsis has been indicated to be heavily influenced by various alleles of candidate genes. Several likely genes have been investigated, some in depth, while others have received less attention. We review the case for genetic susceptibility to sepsis and summarize the literature to date investigating the use of single nucleotide polymorphisms and haplotypes in the search for risk profiles. We discuss the methods in use for structuring associations between complex diseases and genomics. Finally, we summarize the literature to date dealing with risk polymorphisms in candidate genes including tumor necrosis factor (TNF)‐α, lymphotoxin‐α (LTA), interleukin (IL)‐6 and ‐10, as well as others. Drug Dev Res 64:181–194, 2005. © 2005 Wiley‐Liss, Inc.
Drug Development Research – Wiley
Published: Apr 1, 2005
Keywords: pharmacogenomics; immunity; coagulation; disease association; infection; sepsis; single nucleotide polymorphism
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.